IRhythm Technologies Price to Sales Ratio 2015-2024 | IRTC
Historical PS ratio values for IRhythm Technologies (IRTC) over the last 10 years. The current P/S ratio for IRhythm Technologies as of January 08, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| IRhythm Technologies P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-01-07 | 90.57 | 5.01 | |
| 2024-09-30 | 74.24 | $18.06 | 4.11 |
| 2024-06-30 | 107.64 | $17.42 | 6.18 |
| 2024-03-31 | 116.00 | $16.73 | 6.93 |
| 2023-12-31 | 107.04 | $16.16 | 6.62 |
| 2023-09-30 | 94.26 | $15.58 | 6.05 |
| 2023-06-30 | 104.32 | $14.97 | 6.97 |
| 2023-03-31 | 124.03 | $14.32 | 8.66 |
| 2022-12-31 | 93.67 | $13.76 | 6.81 |
| 2022-09-30 | 125.28 | $12.79 | 9.80 |
| 2022-06-30 | 108.03 | $12.24 | 8.83 |
| 2022-03-31 | 157.47 | $11.59 | 13.59 |
| 2021-12-31 | 117.69 | $11.02 | 10.68 |
| 2021-09-30 | 58.56 | $11.07 | 5.29 |
| 2021-06-30 | 66.35 | $10.72 | 6.19 |
| 2021-03-31 | 138.86 | $9.82 | 14.13 |
| 2020-12-31 | 237.21 | $9.64 | 24.60 |
| 2020-09-30 | 238.11 | $9.14 | 26.04 |
| 2020-06-30 | 115.89 | $8.74 | 13.25 |
| 2020-03-31 | 81.35 | $8.99 | 9.05 |
| 2019-12-31 | 68.09 | $8.60 | 7.92 |
| 2019-09-30 | 74.11 | $8.05 | 9.20 |
| 2019-06-30 | 79.08 | $7.49 | 10.56 |
| 2019-03-31 | 74.96 | $6.86 | 10.93 |
| 2018-12-31 | 69.48 | $6.19 | 11.23 |
| 2018-09-30 | 94.66 | $5.67 | 16.71 |
| 2018-06-30 | 81.13 | $5.17 | 15.71 |
| 2018-03-31 | 62.95 | $4.74 | 13.28 |
| 2017-12-31 | 56.05 | $4.40 | 12.72 |
| 2017-09-30 | 51.88 | $6.67 | 7.78 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.799B | $0.493B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $5.669B | 176.81 |
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| Enovis (ENOV) | United States | $2.475B | 16.78 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| 10x Genomics (TXG) | United States | $1.718B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Standard BioTools (LAB) | United States | $0.651B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |